Total Funding
1
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Cyterix Pharmaceuticals is a cancer therapeutics company developing small molecule prodrugs.
- Steven Everett: Founder and CEO
Luis Bayol: CFOPast Role: NGM Biopharmaceuticals, CFO
About the Company
Cyterix Pharmaceuticals, Inc., a privately held cancer therapeutics company, is engaged in the discovery and development of new classes of small molecule prodrugs with improved safety and efficacy over traditional drugs. The company's approach, based on a proprietary technology platform, uniquely enables the design of multiple classes of
anticancer prodrugs that are selectively activated by extra-hepatic cytochrome P450 enzymes that are greatly over-expressed in a broad range of solid tumor and hematologic cancers, but not in normal tissues.
